Drug Profile
Research programme: diagnostic imaging - multimmune
Latest Information Update: 28 Mar 2020
Price :
$50
*
At a glance
- Originator multimmune
- Class Imaging agents; Peptide diagnostics
- Mechanism of Action Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Mar 2020 No recent reports of development identified for research development in Cancer(Diagnosis) in Germany
- 23 Feb 2016 Early research in Cancer (Diagnosis) in Germany (unspecified route)